A5025221069- Antibiotic Resistance in Bacteria
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotic Use and Resistance
- Pharmaceutical and Antibiotic Environmental Impacts
- Pneumonia and Respiratory Infections
- Bacterial Identification and Susceptibility Testing
- Lysosomal Storage Disorders Research
- Antimicrobial Resistance in Staphylococcus
- Mycobacterium research and diagnosis
- Urinary Tract Infections Management
- Glycogen Storage Diseases and Myoclonus
- Carbohydrate Chemistry and Synthesis
- Trypanosoma species research and implications
- Enterobacteriaceae and Cronobacter Research
- Medication Adherence and Compliance
- Reproductive tract infections research
- Child Nutrition and Feeding Issues
- Streptococcal Infections and Treatments
- Cystic Fibrosis Research Advances
- Pharmaceutical studies and practices
- Poxvirus research and outbreaks
- Adsorption, diffusion, and thermodynamic properties of materials
- Personality Disorders and Psychopathology
- Sinusitis and nasal conditions
- Tracheal and airway disorders
Universidad del Noreste
2025
Emory University
2024
University of Alabama at Birmingham
2024
Concordia University Wisconsin
2002-2024
Norfolk and Norwich University Hospitals NHS Foundation Trust
2021-2022
University of Pittsburgh
2022
Texas Tech University Health Sciences Center
2020
Texas Tech University
2020
International Diabetes Federation
2020
Scripps Research Institute
2011
ABSTRACT Between 1 September 2005 and 30 June 2006, 19 medical centers collected 4,180 isolates recovered from clinical specimens patients in intensive care units (ICUs) Canada. The were 2,292 respiratory (54.8%), 738 blood (17.7%), 581 wound/tissue (13.9%), 569 urinary (13.6%). 10 most common organisms isolated 79.5% of all methicillin-susceptible Staphylococcus aureus (MSSA) (16.4%), Escherichia coli (12.8%), Pseudomonas aeruginosa (10.0%), Haemophilus influenzae (7.9%), coagulase-negative...
Patients with Fabry disease (FD) are at a high risk for developing chronic kidney and cardiovascular disease. The availability of specific but costly therapy has elevated the profile this rare condition. This KDIGO conference addressed controversial areas in diagnosis, screening, management FD, included enzyme replacement nonspecific standard-of-care various manifestations FD. Despite marked advances patient care improved overall outlook, there is need to better understand pathogenesis...
ABSTRACT A total of 5,282 bacterial isolates obtained between 1 January and 31 December 2008, inclusive, from patients in 10 hospitals across Canada as part the Canadian Ward Surveillance Study (CANWARD 2008) underwent susceptibility testing. The most common organisms, representing 78.8% all clinical specimens, were follows: Escherichia coli (21.4%), methicillin-susceptible Staphylococcus aureus (MSSA; 13.9%), Streptococcus pneumoniae (10.3%), Pseudomonas aeruginosa (7.1%), Klebsiella...
The PRoposing Early Disease Indicators for Clinical Tracking in Fabry (PREDICT-FD) initiative aimed to reach consensus among a panel of global experts on early indicators disease progression that may justify FD-specific treatment initiation.Anonymous feedback from panellists via online questionnaires was analysed using modified Delphi technique. Questionnaires and data were managed by an independent administrator directed two non-voting cochairs. First, possible renal, cardiac...
Abstract Introduction Mild cognitive impairment (MCI) is a critical stage in the Alzheimer’s Disease and Related Dementias (ADRD) continuum. The speed of decline from MCI to dementia highly variable. Little known, however, whether sleep deficiencies (e.g., short duration, disturbed sleep) accelerate this process. This study aimed examine individuals who experienced prior onset were at an increased risk faster decline. Methods retrospective cohort utilizes survey data Health Retirement Study...
To determine whether maternal antenatal therapy with vitamin K and phenobarbital prevents intracranial hemorrhage in premature newborns. Women at high risk for spontaneous or indicated delivery before 34 weeks' gestation were randomly assigned to receive either placebo phenobarbital. All patients received betamethasone antibiotics managed uniformly by a single perinatal group one hospital. newborns the same nursery neonatal group. Two independent interpretations of head ultrasound...
Fabry disease is an X-linked lysosomal storage disorder caused by a deficiency of α-galactosidase A. Symptoms include neuropathic pain and gastrointestinal problems, such as diarrhoea. To inform support the design Phase III clinical trial for new oral treatment disease, this study evaluated patients' experiences symptoms, impact symptoms on their quality life, views participating in trials.An online survey questionnaire was distributed to patients with through relevant patient organisations....
ABSTRACT From 1997 to 1999, 94 study centers in 15 European, 3 North American, and 2 South American countries contributed 2,632 isolates of Streptococcus pneumoniae an international antimicrobial susceptibility testing study. Only 62.0% were susceptible penicillin, while 22.3% penicillin intermediate 15.6% resistant. Resistance trimethoprim-sulfamethoxazole (24.4%), azithromycin (26.0%), clarithromycin (27.1%) was also highly prevalent. For the penicillin-resistant ( n = 411), MICs at which...
The clinical onset of Fabry disease, a rare, X-linked, multisystemic disorder, is marked by neuropathic pain. Males suffer extensively from this disease. Females, as genetic 'carriers', have traditionally been viewed either asymptomatic or mildly afflicted with disease.To describe Fabry-related pain and compare experiences between the sexes. Patients' perceptions physician assessments were also examined.A disease-specific questionnaire was accessible on-line (www.fabry.org) mailed to 552...
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTDetermination of Penicillin G in OJ. L. Johnson, W. A. Struck, E. J. Scott, and StaffordCite this: Anal. Chem. 1953, 25, 10, 1490–1492Publication Date (Print):October 1, 1953Publication History Published online1 May 2002Published inissue 1 October 1953https://pubs.acs.org/doi/10.1021/ac60082a021https://doi.org/10.1021/ac60082a021research-articleACS PublicationsRequest reuse permissionsArticle Views76Altmetric-Citations4LEARN ABOUT THESE...
Abstract Background Fabry disease (FD) is a rare X-linked lysosomal storage disorder with heterogeneous clinical presentation. Patients FD may exhibit early signs/symptoms including neuropathic pain, gastrointestinal complaints, and dermatologic manifestations. ultimately progress to renal, neurologic, cardiac dysfunction. Current treatments for have significantly improved the management outcomes patients FD, but important convenience limitations still exist. Methods To illuminate impact of...